Fifth Third Bancorp lowered its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 14.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 64,148 shares of the health services provider’s stock after selling 10,485 shares during the period. Fifth Third Bancorp owned 0.12% of Maximus worth $3,412,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the stock. Jefferies Financial Group Inc. purchased a new position in Maximus in the third quarter valued at approximately $556,000. Leuthold Group LLC bought a new position in Maximus during the third quarter valued at $304,000. Fulcrum Asset Management LLP bought a new position in Maximus during the third quarter valued at $179,000. CenterBook Partners LP purchased a new stake in Maximus in the third quarter worth $256,000. Finally, Chicago Partners Investment Group LLC purchased a new stake in Maximus in the third quarter worth $337,000. Institutional investors own 97.21% of the company’s stock.
Key Stories Impacting Maximus
Here are a few of the latest stories about MMS:
- Positive Sentiment: Maximus completed its $660 million acquisition of Agile Defense. The deal expands its national-security business, which is expected to approach 10% of company revenue. Agile Defense acquisition
- Neutral Sentiment: Fiscal Q4 revenue was $1.30 billion, roughly in line with estimates, but declined 1.3% year over year. Quarterly earnings report
- Negative Sentiment: Fiscal 2027 EPS guidance of $7.50 to $8.00 is below the $8.36 consensus forecast. This earnings outlook shortfall may outweigh the stronger revenue outlook for investors, particularly as management also flagged near-term headwinds. Earnings call highlights
Insider Transactions at Maximus
Maximus Trading Down 5.0%
Shares of MMS opened at $62.00 on Friday. The firm’s 50 day simple moving average is $60.08 and its 200 day simple moving average is $62.96. The company has a market capitalization of $3.25 billion, a P/E ratio of 9.16 and a beta of 0.57. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. Maximus, Inc. has a 1-year low of $51.04 and a 1-year high of $100.00.
Maximus (NYSE:MMS – Get Free Report) last announced its earnings results on Thursday, November 19th. The health services provider reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.26. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same period in the previous year, the business posted $1.62 earnings per share. Maximus’s revenue for the quarter was down 1.3% on a year-over-year basis. Maximus has set its FY 2027 guidance at 7.500-8.000 EPS. Sell-side analysts forecast that Maximus, Inc. will post 8.03 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be given a $0.33 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.32 annualized dividend and a yield of 2.1%. Maximus’s payout ratio is 19.50%.
Analysts Set New Price Targets
Several research analysts have recently weighed in on the company. Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Weiss Ratings restated a “hold (c-)” rating on shares of Maximus in a research note on Friday, November 13th. Finally, Zacks Research raised shares of Maximus from a “strong sell” rating to a “hold” rating in a report on Thursday, October 1st. Two investment analysts have rated the stock with a Hold rating. According to data from MarketBeat, the company currently has an average rating of “Hold”.
View Our Latest Report on Maximus
Maximus Profile
Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.
Featured Articles
- Five stocks we like better than Maximus
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
